11/14/2024 3:53 PM | Nantahala Capital Management, LLC (Filed by) ZEVRA THERAPEUTICS, INC. (Subject) Zevra Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
11/04/2024 1:15 PM | VANGUARD GROUP INC (Filed by) ZEVRA THERAPEUTICS, INC. (Subject) Zevra Therapeutics (Subject)
| Form SC 13G/A | |
10/16/2024 3:46 PM | Watton Corey Michael (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/13/2024 3:17 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/09/2024 3:54 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 424B5 | |
07/17/2024 4:54 PM | Clifton R. LaDuane (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/16/2024 3:39 PM | Anderson Thomas (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
07/12/2024 3:37 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/12/2024 3:23 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 424B2 Transaction specifc information for a delayed shelf offering | |
07/09/2024 8:23 AM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 4:11 PM | Thompson Rahsaan (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
06/25/2024 4:13 PM | Thompson Rahsaan (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 11:15 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form EFFECT | |
05/15/2024 8:15 PM | Watton Corey Michael (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 8:18 PM | Calder Douglas W (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 8:20 PM | FAVORITO TAMARA A (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 8:28 PM | DIXON WENDY L (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 8:31 PM | Bode John B (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 8:05 PM | Anderson Thomas (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 8:13 PM | Shih Alvin (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/08/2024 6:54 AM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/29/2024 6:49 AM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form DEFA14A | |
04/10/2024 3:23 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 424B3 | |
04/10/2024 6:46 AM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/08/2024 11:15 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form EFFECT | |
04/05/2024 6:39 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form S-3/A | |
04/01/2024 4:27 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/26/2024 7:28 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2024 6:34 AM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/04/2024 7:24 AM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 8:39 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
02/02/2024 8:22 PM | Schafer Joshua (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 7:13 PM | Guenther Sven (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 7:14 PM | Mickle Christal M M (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 7:17 PM | Sangiovanni Timothy J. (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 7:08 PM | Shih Alvin (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 7:10 PM | McFarlane Neil F. (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 7:11 PM | Clifton R. LaDuane (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 6:13 AM | Shih Alvin (Reporting) ZEVRA THERAPEUTICS, INC. (Issuer) Zevra Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/29/2024 4:25 PM | BlackRock Inc. (Filed by) ZEVRA THERAPEUTICS, INC. (Subject) Zevra Therapeutics (Subject)
| Form SC 13G | |
01/23/2024 6:37 AM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
The only candlestick pattern worth a darn (Ad) It’s widely known that 80% of daily market action is driven by Wall Street algorithms…
Now, most people think of the algorithms are “bad”
When in reality, they are neither good nor bad…
They are simply programmed to buy and sell certain stocks over and over again…
But here is the thing…
They are predictable…
They typically buy the same stocks at the same levels over and over again… Follow this link here and enter your email address to sign up… |
01/08/2024 7:03 AM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/27/2023 6:48 AM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/21/2023 6:40 PM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 424B5 | |
11/20/2023 6:36 AM | ZEVRA THERAPEUTICS, INC. (Filer) Zevra Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |